REPLIGEN CORP (RGEN) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for REPLIGEN CORP (RGEN): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 49/100 — a percentile rank of REPLIGEN CORP’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $10.8B |
| P / E | 261.2× |
| P / S | 13.8× |
| EV / EBITDA | 71.3× |
| Gross margin | 53.8% |
| Operating margin | 8.2% |
| Net margin | 5.3% |
| Return on equity | 2.0% |
| ROIC | 2.5% |
| Revenue growth | 16.5% |
| Debt / equity | 0.3× |
| Dividend yield | 0.0% |
Is REPLIGEN CORP overvalued? P/E looks overvalued vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from REPLIGEN CORP’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact